Cancer is a package of diseases marked by uncurbed growth and proliferation of anomalous cells. The illness is generally assumed to be the fruit of the impact of assorted outside factors and inner forces, such as tobacco smoking, radiation exposure, chemicals’ influences, infectious agents, inherited gene mutations, hormonal disorders, immune system conditions and mutations of other origins, among others.
Thus far, the Cancer Market has already seen noticeable progress in early-stage tumor detection and cure globally. The market for Cancer diagnostics is close to explosive growth, promising to reach approximately EUR 4 billion in value by end-2015. Further, technology discoveries will continue to afford many chances of demystifying the genetic components of the sickness, identifying specific tumor types, and observing biological reaction to cancer treatments. However, the bulk of presently available therapies do not fully protect against some unwelcomed side-effects.
The research reports in this Catalogue present global, regional and nation-level analyses of the Cancer Market development trends over different time spans. The research reports identify major bizopps emerging in the Cancer Market; examine versatile Cancer diagnostic test technologies along with their applications, besides looking into other Cancer Market issues. The research reports also profile the top players and would-be entrants, as well as offer test volume and sales projections.
Publications found:
1,809
Sort by:
Global Cancer Immunotherapy Market Analysis & Forecast to 2023: Antibody Drug Conjugates (ADCs), Bispecific Monoclonal Antibodies, Cancer Vaccines, Cytokines, Interferons, Chimeric Antigen Receptor (CAR) T-Cell Therapy, PD-1/PD-L1 inhibitors, Dendritic Cells, Checkpoint Inhibitors, Adopted Cell Therapy (ACT) & IDO Inhibitors
US$ 4,900.00
Within the cancer therapeutics space, which today is worth over $100 billion globally, immunotherapeutic drugs have gained worldwide acceptance. This is because they are targeted therapeutics that hav...
January 2020
450 pages
Global Neoantigen Cancer Vaccine Market : Focus on Application, Approach, Type, Line of Therapy, Treatment Strategy, Country Data (15 Countries),and Competitive Landscape – Analysis and Forecast, 2023-2030
US$ 5,000.00
Key Questions Answered in this Report:What are the major market drivers, challenges, and opportunities in the global neoantigen cancer vaccine market?What are the underlying structures resulting in th...
December 2019
255 pages
High-Grade Glioma Global Clinical Trials Review, H2, 2019
US$ 2,500.00
... of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports ...
December 2019
269 pages
Aplastic Anemia Global Clinical Trials Review, H2, 2019
US$ 2,500.00
... to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status ...
December 2019
241 pages
Malignant Mesothelioma Global Clinical Trials Review, H2, 2019
US$ 2,500.00
... to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status ...
December 2019
383 pages
T-Cell Leukemia Global Clinical Trials Review, H2, 2019
US$ 2,500.00
... of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports ...
December 2019
221 pages
Colorectal Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2019
US$ 4,000.00
Colorectal Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2018 SUMMARY GlobalData's Medical Devices sector report, “Colorectal Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2018' provides an overview of Colorectal Cancer Diagnostic Tests currently in pipeline stage. The ...
December 2019
439 pages
Fallopian Tube Cancer Global Clinical Trials Review, H2, 2019
US$ 2,500.00
... of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports ...
December 2019
804 pages
Bladder Cancer Global Clinical Trials Review, H2, 2019
US$ 2,500.00
... of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports ...
December 2019
908 pages
Rectal Cancer Global Clinical Trials Review, H2, 2019
US$ 2,500.00
Rectal Cancer Global Clinical Trials Review, H2, 2019 SUMMARY GlobalData's clinical trial report, “Rectal Cancer Global Clinical Trials Review, H2, 2019' provides an overview of Rectal Cancer clinic...
December 2019
689 pages
Colorectal Cancer: Epidemiology Forecast to 2028
US$ 3,995.00
Colorectal Cancer: Epidemiology Forecast to 2028 SUMMARY Colorectal cancer (CRC) is a cancer that occurs in the large intestine or large bowel (Centers for Disease Control and Prevention, 2019). Mos...
November 2019
47 pages
HER2-Negative Breast Cancer: Epidemiology Forecast to 2028
US$ 3,995.00
HER2-Negative Breast Cancer: Epidemiology Forecast to 2028 SUMMARY Breast cancer is a malignant tumor that originates in the breast tissue. Most breast cancers are invasive tumors that have grown be...
November 2019
61 pages
Breast Cancer Diagnostic and Drug Technologies: Global Markets
US$ 5,500.00
... current report. This report includes market estimates for breast cancer diagnostics (mammography, biopsy and companion diagnostics), therapeutics along with market share of therapeutics by drug class (HER2 inhibitors, mitotic ...
November 2019
150 pages
Global Cancer Registry Software Market Size study, by Type (Standalone Software, Integrated Software), by Deployment Model (On-Premise, Cloud-Based), by Database Type (Commercial Database, Public Database), By Functionality (Cancer Reporting to Meet State and Federal Regulations, Patient Care Management, Medical Research & Clinical Studies, Product Outcome Evaluation), by End-User (Government Organizations & Third-Party Administrators, Hospitals & Medical Practices, Private Players, Pharmaceutical, Biotechnology, and Medical Device Companies, Research Centers) and Regional Forecasts 2019-2026
US$ 3,950.00
Global Cancer Registry Software Market is valued approximately at USD 50.68 million in 2018 and is anticipated to grow with a healthy growth rate of more than 10.5% over the forecast period 2019-2026....
November 2019
200 pages
Global Cancer Vaccine Partnering 2014-2019: Deal trends, players and financials
US$ 2,995.00
... Case studies of real-life Cancer Vaccine deals Access to Cancer Vaccine contract documents Leading Cancer Vaccine deals by value since 2014 Most active Cancer Vaccine dealmakers since 2014 In Global Cancer Vaccine Partnering 2014-2019: Deal trends, players, financials and ...
November 2019
120 pages
Global Oncology Partnering 2014-2019: Deal trends, players and financials
US$ 3,495.00
... , Vomiting, Chemotherapy, Radiotherapy, Adenocarcinoma, Basal cell carcinoma, Bile duct cancer, Bladder cancer, Bone cancer, Brain cancer, Breast cancer, Cervical cancer, Colorectal cancer, Endometrial, Esophageal cancer, Gastric cancer, Head and neck cancer, Kaposi's sarcoma, Kidney cancer, Leukemia, Acute ...
November 2019
2400 pages
Global Cancer Diagnostics Partnering 2014-2019: Deal trends, players and financials
US$ 2,995.00
... Case studies of real-life Cancer Diagnostics deals Access to Cancer Diagnostics contract documents Leading Cancer Diagnostics deals by value since 2014 Most active Cancer Diagnostics dealmakers since 2014 In Global Cancer Diagnostics Partnering 2014-2019: Deal trends, players, financials and ...
November 2019
400 pages
Ovarian Cancer: Opportunity Analysis and Forecasts to 2028
US$ 10,995.00
Ovarian Cancer: Opportunity Analysis and Forecasts to 2028 SUMMARY Ovarian cancer is a rare gynecological disease that spans a broad range of genetic and histological subtypes, for which platinum-ba...
September 2019
162 pages
Radiotherapy Market by Product (Radiotherapy Devices, Software, Service), Procedure (EBRT, Brachytherapy, Systemic Radiotherapy), Technology (IMRT, SRT, VMAT, HDRBT, LDRBT, PDRBT), Application (Prostate, Breast) - Global Forecast to 2025
US$ 4,475.00
... Cobalt-60 based teletherapy Proton Therapy Internal Beam Radiotherapy Brachytherapy Systemic Radiotherapy Market by Product Radiotherapy Devices External beam radiotherapy systems Conventional Linear Accelerators (LINAC) Conventional ...
September 2019
327 pages
Cancer Diagnostics Companies in China
US$ 1,800.00
This study focuses on China’s Cancer Diagnostics industry assessments and company profiles. In the two past decades, the industry has been ... 1,500 reports focusing on the Chinese markets, industry forecasts and company profiles. We provide hard-to-find market data and analyses. Our ...
September 2019
53 pages
Cancer Diagnostics Industry Forecasts - China Focus
US$ 1,800.00
This study focuses on China’s Cancer Diagnostics industry forecasts. In the two past decades, the ... -term forecasts through 2023 and 2028 are presented. The primary and secondary research is done in China in ... reports focusing on the Chinese markets, industry forecasts and company profiles. We provide hard-to-find ...
September 2019
103 pages
Cancer Diagnostics Markets in China
US$ 4,000.00
China's demand for Cancer Diagnostics has grown at a fast pace in the past decade. In the next ... ) and/or US dollars. Our market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous ...
September 2019
213 pages
Prostate Cancer: Epidemiology Forecast to 2028
US$ 3,995.00
Prostate Cancer: Epidemiology Forecast to 2028 SUMMARY Prostate cancer is a malignancy in the prostate gland, which is located below the bladder and in front of the rectum in males. Worldwide, about...
August 2019
48 pages
Colorectal Cancer - Global Market Outlook (2017-2026)
US$ 4,150.00
According to Stratistics MRC, the Global Colorectal Cancer Market is accounted for $9.22 billion in 2017 and is expected to reach $13.01 billion ... primary one being greater prevalence of colorectal cancer. Some of the key players profiled in the Colorectal Cancer market include Abbott Laboratories, Amgen Inc., ...
August 2019
137 pages
Pancreatic Cancer - Global Market Outlook (2017-2026)
US$ 4,150.00
According to Stratistics MRC, the Global Pancreatic Cancer market is accounted for $1,904.20 million in 2017 and is expected to reach $4,728.19 ... sector over the globe. Some of the key players in the Pancreatic Cancer market include Novartis Ag, Eli Lily and Company, F. Hoffmann-La Roche AG, Pharmacyte ...
August 2019
183 pages
Prostate Cancer - Global Market Outlook (2017-2026)
US$ 4,150.00
According to Stratistics MRC, the Global Prostate Cancer market is growing at a CAGR of 10.3% during the forecast period. Some of the key ... commodities, which is likely to boost county market growth. Some of the key players profiled in the Prostate Cancer Market include Astellas, Inc., AstraZeneca plc, Bristol ...
August 2019
155 pages
Interventional oncology Market by Procedure [Embolization (TARE, TACE), Ablation (Thermal Ablation (Microwave, RF Ablation))], Product [Embolization (SIR-Spheres, TheraSpheres)], Application (Liver, Lung, Breast), and End User - Global Forecast to 2025
US$ 4,175.00
Interventional oncology Market by Procedure [Embolization (TARE, TACE), Ablation (Thermal Ablation (Microwave, RF Ablation)], Product [ ...
August 2019
251 pages
Ovarian Cancer: Epidemiology Forecast to 2028
US$ 3,995.00
Ovarian Cancer: Epidemiology Forecast to 2028 SUMMARY Ovarian cancer is the most lethal gynecologic cancer and overall a leading cause of cancer incidence and mortality worldwide. The disease is def...
July 2019
46 pages
Global Cancer or Tumor Profiling Market Size study, By Technology (Immunoassays, Hybridization, Next Generation Sequencing, Mass Spectrometry, other technologies), By Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal cancer, melanoma cancer, other cancer), By Applications (Clinical Application, Research Applications) and Regional Forecasts 2019-2026.
US$ 3,950.00
... by 2025. Increasing number of breast cancer cases would supplement global Cancer or Tumor profiling market for the forecasted period. However, ... , the Cancer or Tumor Profiling market is segmented into technology, cancer type and application. The technology segment of global Cancer or Tumor Profiling market is ...
July 2019
200 pages
Global Cancer/Tumor Profiling Market Size study, by Technology (Immunoassays, Hybridization, Next Generation Sequencing, Mass Spectrometry and other technologies) Cancer type (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal cancer, melanoma cancer and other cancer) Applications (Clinical Application and Research Applications) and Regional Forecasts 2019-2026.
US$ 3,950.00
... – 2019 to 2026 Target Audience of the Global Cancer/Tumor Profiling Market in Market Study: Key Consulting Companies & Advisors Large, medium-sized, and small enterprises Venture capitalists Value ...
July 2019
200 pages
Pancreatic cancer Global Clinical Trials Review, H2, 2019
US$ 2,500.00
Pancreatic cancer Global Clinical Trials Review, H2, 2019 SUMMARY GlobalData's clinical trial report, “Pancreatic cancer Global Clinical Trials Review, H2, 2019' provides an overview of End-Stage Ki...
July 2019
2082 pages
Tumor Infiltrating Lymphocytes: A New Frontier in Cancer Immunotherapy
US$ 2,500.00
REPORT INCLUDES: An overview of Tumor Infiltrating Lymphocytes (TILs) for the treatment of metastatic cancer Discussion of the development of TIL as a ... ATCT in a variety of other solid tumors Comparison between two main technologies of tumor immunotherapy, chimeric antibody receptor engineered T Cell ( ...
July 2019
21 pages
